Headlands Technologies »

Enanta Pharmaceuticals shares owned by Headlands Technologies

Quarter-by-quarter ownership of Enanta Pharmaceuticals (ENTA) shares owned by Headlands Technologies from 13F filings

Historical chart of Headlands Technologies investment in Enanta Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Enanta Pharmaceuticals held by Headlands Technologies consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Enanta Pharmaceuticals by Headlands Technologies

Quarter filed Position value Share count Share price at filing
2024-03-31 $18k 1.1k 17.46

More positions owned by Headlands Technologies

NVIDIA Corporation (NVDA)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Apple (AAPL)
Microsoft Corporation (MSFT)
Linde SHS (LIN)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Vale S A Sponsored Ads (VALE)
Asml Holding N V N Y Registry Shs (ASML)
Rio Tinto Sponsored Adr (RIO)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
Applied Materials (AMAT)
Petroleo Brasileiro Sa Petro Sponsored Adr (PBR)
Broadcom (AVGO)
At&t (T)
Verisign (VRSN)

View all positions for Headlands Technologies

Top funds holding Enanta Pharmaceuticals

Farallon Capital Management
Morgan Stanley
Vanguard Group
BlackRock
Armistice Capital
Krensavage Asset Management
Marshall Wace
Northern Trust
Caligan Partners
Acadian Asset Management
Millennium Management
Assenagon Asset Management
Soleus Capital Management
D. E. Shaw & Co
Bank of America Corporation

View all funds holding Enanta Pharmaceuticals